Nasdaq · CIK 0002032545
CJMB CALLAN JMB INC.
Insider trading from SEC Form 4. Last filing Jun 1, 2026. Close $2.28 on Oct 9, 2026, +225% from the 52-week low and -49% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Price and insider trades, last year
CJMBOct 9, 2026 · close 2.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CALLAN JMB INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Gerald Dial director buy | $7,620 10,000 shares | +500% | +2% from low-82% from high | |
| 28Weak | David J Croyle Chief Medical Officer buy | $18k 10,195 shares | +1% | +76% from low-66% from high | |
| 28Weak | David J Croyle Chief Medical Officer buy | $26k 14,805 shares | +2% | +62% from low-69% from high | |
| 49Moderate | Gerald Dial director buy | $2,409 2,000 shares | - | +2% from low-82% from high | |
| 56Moderate | Wayne D Williams CEO, Chairman and President buy | $8,650 5,000 shares | +6% | +26% from low-72% from high | |
| 46Moderate | Wayne D Williams CEO, Chairman and President buy | $27k 15,798 shares | +1% | +29% from low-71% from high | |
| 59Moderate | Wayne D Williams CEO, Chairman and President buy | $73k 44,545 shares | +178% | +27% from low-72% from high | |
| 49Moderate | Liberty Smith Duke director buy | $2,334 1,512 shares | - | +8% from low-76% from high | |
| 38Weak | David J Croyle Chief Medical Officer buy | $113k 25,000 shares | +3% | +17% from low-31% from high | |
| 41Moderate | David J Croyle Chief Medical Officer buy | $98k 24,375 shares | - | - | |
| 46Moderate | Wayne D Williams CEO and President buy | $253k 63,125 shares | +3% | - |
Transactions
The last 21 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Gerald Dial director | POpen-market purchase Common Stock | +10,000 | $0.76 | $7,620 | 12,000 | Jun 1, 2026 |
| Feb 4, 2025 | Gerald Dial director | AGrant or award Option (Right to Buy)derivative | +25,000 | $4.00 | $100k | 25,000 | Jun 1, 2026 |
| Mar 20, 2026 | David J Croyle Chief Medical Officer | POpen-market purchase Common Stockindirect: By Rollover IRA | +10,195 | $1.75 | $18k | 800,000 | Mar 26, 2026 |
| Mar 6, 2026 | David J Croyle Chief Medical Officer | POpen-market purchase Common Stockindirect: By Rollover IRA | +14,805 | $1.76 | $26k | 789,805 | Mar 10, 2026 |
| Dec 30, 2025 | Gerald Dial director | POpen-market purchase Common Stock | +461 | $1.22 | $562 | 461 | Jan 6, 2026 |
| Dec 30, 2025 | Gerald Dial director | POpen-market purchase Common Stock | +1,539 | $1.20 | $1,847 | 2,000 | Jan 6, 2026 |
| Feb 4, 2025 | Gerald Dial director | AGrant or award Option (Right to Buy)derivative | +25,000 | $4.00 | $100k | 25,000 | Jan 6, 2026 |
| Dec 16, 2025 | Wayne D Williams CEO, Chairman and President | POpen-market purchase Common Stockindirect: By Health Hero America, LLC | +5,000 | $1.73 | $8,650 | 84,355 | Dec 18, 2025 |
| Dec 11, 2025 | Wayne D Williams CEO, Chairman and President | POpen-market purchase Common Stock | +62 | $1.79 | $111 | 2,262,562 | Dec 15, 2025 |
| Dec 12, 2025 | Wayne D Williams CEO, Chairman and President | POpen-market purchase Common Stock | +4,926 | $1.75 | $8,621 | 2,267,488 | Dec 15, 2025 |
| Dec 15, 2025 | Wayne D Williams CEO, Chairman and President | POpen-market purchase Common Stockindirect: By Health Hero America, LLC | +10,810 | $1.70 | $18k | 79,355 | Dec 15, 2025 |
| Dec 10, 2025 | Wayne D Williams CEO, Chairman and President | POpen-market purchase Common Stockindirect: By Health Hero America, LLC | +13,689 | $1.65 | $23k | 38,689 | Dec 12, 2025 |
| Dec 11, 2025 | Wayne D Williams CEO, Chairman and President | POpen-market purchase Common Stockindirect: By Health Hero America, LLC | +30,856 | $1.65 | $51k | 68,545 | Dec 12, 2025 |
| Dec 8, 2025 | Liberty Smith Duke director | POpen-market purchase Common Stock | +900 | $1.56 | $1,404 | 900 | Dec 10, 2025 |
| Dec 9, 2025 | Liberty Smith Duke director | POpen-market purchase Common Stock | +612 | $1.52 | $930 | 1,512 | Dec 10, 2025 |
| Feb 4, 2025 | Liberty Smith Duke director | AGrant or award Option (Right to Buy)derivative | +25,000 | $4.00 | $100k | 25,000 | Dec 10, 2025 |
| Mar 27, 2025 | David J Croyle Chief Medical Officer | POpen-market purchase Common Stockindirect: By Rollover IRA | +25,000 | $4.50 | $113k | 775,000 | Apr 3, 2025 |
| Feb 5, 2025 | Wayne D Williams CEO and President | POpen-market purchase Common Stock | +12,500 | $4.00 | $50k | 2,262,500 | Mar 14, 2025 |
| Feb 5, 2025 | David J Croyle Chief Medical Officer | POpen-market purchase Common Stockindirect: By Warehouse Asset Management, LLC | +24,375 | $4.00 | $98k | 24,375 | Mar 14, 2025 |
| Feb 5, 2025 | Wayne D Williams CEO and President | POpen-market purchase Common Stockindirect: By Warehouse Asset Management, LLC | +25,625 | $4.00 | $103k | 25,625 | Mar 14, 2025 |
| Feb 5, 2025 | Wayne D Williams CEO and President | POpen-market purchase Common Stockindirect: By Health Hero America, LLC | +25,000 | $4.00 | $100k | 25,000 | Mar 14, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- David J CroyleChief Medical Officer
- Gerald Dialdirector
- Liberty Smith Dukedirector
- Wayne D WilliamsCEO, Chairman and President
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.